HCA Healthcare Inc. (HCA)
HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
HCA Healthcare's Q2 earnings rose 24% year over year on stronger patient volumes. EPS for 2025 is expected to be within $25.5-$27, up from the earlier view of $24.05-$25.85.
HCA Healthcare (HCA) Beats Q2 Earnings and Revenue Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $6.84 per share, beating the Zacks Consensus Estimate of $6.19 per share. This compares to earnings of $5.5 per share a year ago.
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Ahead of HCA (HCA) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top-and-bottom-line estimates for HCA (HCA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
HCA Healthcare to Report Q2 Earnings: Key Estimates to Note
The Zacks Consensus Estimate for HCA's Q2 EPS and revenues suggests a year-over-year upside despite higher costs and surgery volume pressure.
HCA Healthcare (HCA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 stocks to hold through any market crash
J.P. Morgan research suggests the probability of a U.S. recession in 2025 is dropping below 50% from its 60% peak, now that the Trump administration is pulling punches on some of its more aggressive tariff policies, allowing the S&P 500 to rebound after dipping into correction territory back in March. However, the risk is still high.
HCA (HCA) Upgraded to Buy: Here's Why
HCA (HCA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
